JPMorgan Chase & Co. vs Merck & Co., Inc.
JPMorgan Chase & Co. is worth $947.643B, 2.5× the $377.724B market cap of Merck & Co., Inc.. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $947.643B | $377.724B |
| Global rank | #1 | #2 |
| Share price | $356.50 | $153.10 |
| Change | -1.53% | +17.39% |
| Revenue | $181.847B | $65.011B |
| Net income | $57.048B | $18.254B |
| Country | United States | United States |
| Sector | Financial Services | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is JPMorgan Chase & Co. bigger than Merck & Co., Inc.?
- JPMorgan Chase & Co. has a market cap of $947.643B against $377.724B for Merck & Co., Inc., making it 2.5 times as valuable.
- Which company earns more, JPM or MRK?
- JPMorgan Chase & Co. reported net income of $57.048B and Merck & Co., Inc. reported $18.254B in their most recent annual periods.